Nearly 20% of cancer drugs in parts of Sub-Saharan Africa fail quality tests – Study
The investigation, featured in The Lancet Global Health, examined 251 samples of seven widely prescribed cancer treatments sourced from hospitals, licensed pharmacies, and unregulated vendors in Ethiopia, Kenya, Malawi, and Cameroon between April 2023 and February 2024

